Author

R. Delattre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

B. Gaborieau· 2 shared J.-D. Ricard· 2 shared L. Debarbieux· 2 shared E. Denamur· 1 shared F. Haddad· 1 shared J. Guedj· 1 shared J. Seurat· 1 shared N. Dufour· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. Gaborieau

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Variable effects on virulence of bacteriophage resistance mechanisms in extraintestinal pathogenic Escherichia coli

B. Gaborieau, R. Delattre, S. Adiba, O. Clermont, E. Denamur, J.-D. Ricard, L. Debarbieux

This study examines phage resistance mechanisms in E. coli and finds that resistance can be predicted from in vitro conditions, often reduces virulence, and can be mitigated with phage cocktails.

bioRxiv · Sep 1, 2022 · PreprintMicrobiology

Combination of in vivo phage therapy data with in silico model highlights key parameters for treatment efficacy

R. Delattre, J. Seurat, F. Haddad, T.-T. Nguyen, B. Gaborieau, R. Kane, N. Dufour, J.-D. Ricard, J. Guedj, L. Debarbieux

The paper combines in vivo phage therapy data with an in silico model to identify key parameters affecting treatment efficacy in bacterial pneumonia.

bioRxiv · Mar 4, 2021Microbiology